Analyst firms · H.C. Wainwright · AADI

H.C. Wainwright AADI price target and rating history

Aadi Bioscience Inc. (AADI) · Health Care

H.C. Wainwright rates Aadi Bioscience Inc. (AADI) Neutral with a $49 price target, as of its latest action on Dec 15, 2023. It has published 3 rating actions on AADI since August 2021, including 0 upgrades and 1 downgrade.

Current rating
Neutral
Price target
$49
Median target, all firms
Too few
Actions on AADI
3

H.C. Wainwright price target on AADI

$49$48$4720222023202420252026
H.C. Wainwright price target on AADI, each point a stated target, August 2021 to November 2021.

Every H.C. Wainwright rating on AADI

Questions about H.C. Wainwright and AADI

What is H.C. Wainwright's price target for AADI?
H.C. Wainwright's latest stated price target for Aadi Bioscience Inc. (AADI) is $49, from its action on Nov 24, 2021.
What is H.C. Wainwright's rating on AADI?
H.C. Wainwright rates AADI Neutral, a neutral rating, as of Dec 15, 2023.
When did H.C. Wainwright last change its view on AADI?
On Dec 15, 2023, H.C. Wainwright downgrades to Neutral from Buy.

All H.C. Wainwright ratingsAADI news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.